367 related articles for article (PubMed ID: 23443013)
1. Proteomic studies of urinary biomarkers for prostate, bladder and kidney cancers.
Wood SL; Knowles MA; Thompson D; Selby PJ; Banks RE
Nat Rev Urol; 2013 Apr; 10(4):206-18. PubMed ID: 23443013
[TBL] [Abstract][Full Text] [Related]
2. Urine microRNAs as potential noninvasive biomarkers in urologic cancers.
Mlcochova H; Hezova R; Stanik M; Slaby O
Urol Oncol; 2014 Jan; 32(1):41.e1-9. PubMed ID: 24035473
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic potential in bladder cancer of a panel of tumor markers (calreticulin, gamma -synuclein, and catechol-o-methyltransferase) identified by proteomic analysis.
Iwaki H; Kageyama S; Isono T; Wakabayashi Y; Okada Y; Yoshimura K; Terai A; Arai Y; Iwamura H; Kawakita M; Yoshiki T
Cancer Sci; 2004 Dec; 95(12):955-61. PubMed ID: 15596044
[TBL] [Abstract][Full Text] [Related]
4. The emerging role of extracellular vesicles as biomarkers for urogenital cancers.
Nawaz M; Camussi G; Valadi H; Nazarenko I; Ekström K; Wang X; Principe S; Shah N; Ashraf NM; Fatima F; Neder L; Kislinger T
Nat Rev Urol; 2014 Dec; 11(12):688-701. PubMed ID: 25403245
[TBL] [Abstract][Full Text] [Related]
5. [Cytologic tumor diagnosis in urology].
Kelâmi A; Kirstaedter HJ
Z Urol Nephrol; 1969; 62(7):519-27. PubMed ID: 5407745
[No Abstract] [Full Text] [Related]
6. Emerging Utility of Urinary Cell-free Nucleic Acid Biomarkers for Prostate, Bladder, and Renal Cancers.
Lin SY; Linehan JA; Wilson TG; Hoon DSB
Eur Urol Focus; 2017 Apr; 3(2-3):265-272. PubMed ID: 28753876
[TBL] [Abstract][Full Text] [Related]
7. Urinary exosomal shuttle RNA: Promising cancer diagnosis biomarkers of lower urinary tract.
De Palma G; Di Lorenzo VF; Krol S; Paradiso AV
Int J Biol Markers; 2019 Jun; 34(2):101-107. PubMed ID: 30862241
[TBL] [Abstract][Full Text] [Related]
8. Differences in Urinary Amino Acid Patterns in Individuals with Different Types of Urological Tumor Urinary Amino Acid Patterns as Markers of Urological Tumors.
Duskova K; Vesely S; DO Carmo Silva J; Cernei N; Zitka O; Heger Z; Adam V; Havlova K; Babjuk M
In Vivo; 2018; 32(2):425-429. PubMed ID: 29475932
[TBL] [Abstract][Full Text] [Related]
9. Molecular diagnostic trends in urological cancer: biomarkers for non-invasive diagnosis.
Urquidi V; Rosser CJ; Goodison S
Curr Med Chem; 2012; 19(22):3653-63. PubMed ID: 22680923
[TBL] [Abstract][Full Text] [Related]
10. [Comparative cytodiagnosis in urology].
Schiffer A; Lymberopoulos S; Charvat A
Z Urol Nephrol; 1968 Jun; 61(6):367-74. PubMed ID: 4178464
[No Abstract] [Full Text] [Related]
11. Proteomic studies in urological malignancies.
Ferguson RE; Selby PJ; Banks RE
Contrib Nephrol; 2004; 141():257-79. PubMed ID: 14650238
[No Abstract] [Full Text] [Related]
12. miR-21-5p, miR-141-3p, and miR-205-5p levels in urine-promising biomarkers for the identification of prostate and bladder cancer.
Ghorbanmehr N; Gharbi S; Korsching E; Tavallaei M; Einollahi B; Mowla SJ
Prostate; 2019 Jan; 79(1):88-95. PubMed ID: 30194772
[TBL] [Abstract][Full Text] [Related]
13. Long Noncoding RNAs as Innovative Urinary Diagnostic Biomarkers.
Brisotto G; Guerrieri R; Colizzi F; Steffan A; Montico B; Fratta E
Methods Mol Biol; 2021; 2292():73-94. PubMed ID: 33651353
[TBL] [Abstract][Full Text] [Related]
14. [Urinary marker-old wine in new bottles?].
Fischer K
Urologe A; 2018 Sep; 57(9):1040-1047. PubMed ID: 30043290
[TBL] [Abstract][Full Text] [Related]
15. Carcinoma of urinary tract. Clinical significance of urinary phosphokinase activity in diagnosis.
Block NL; Jaksy J; Tessler AN
Urology; 1974 Aug; 4(2):174-81. PubMed ID: 4850881
[No Abstract] [Full Text] [Related]
16. [Molecular diagnostics in urologic oncology. Detection of nucleic acids in urine samples].
Müller M; Goessl C; Krause H; Miller K
Urologe A; 2003 May; 42(5):660-8. PubMed ID: 12750801
[TBL] [Abstract][Full Text] [Related]
17. The clinical significance of increased activity of urinary lactic dehydrogenase.
Kiser WS; Riggins RS
J Urol; 1966 Oct; 96(4):559-64. PubMed ID: 4162696
[No Abstract] [Full Text] [Related]
18. Revealing urologic diseases by proteomic techniques.
Lee SW; Lee KI; Kim JY
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 815(1-2):203-13. PubMed ID: 15652810
[TBL] [Abstract][Full Text] [Related]
19. Altered Proteome of Extracellular Vesicles Derived from Bladder Cancer Patients Urine.
Lee J; McKinney KQ; Pavlopoulos AJ; Niu M; Kang JW; Oh JW; Kim KP; Hwang S
Mol Cells; 2018 Mar; 41(3):179-187. PubMed ID: 29562735
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA in prostate, bladder, and kidney cancer.
Martens-Uzunova ES; Böttcher R; Croce CM; Jenster G; Visakorpi T; Calin GA
Eur Urol; 2014 Jun; 65(6):1140-51. PubMed ID: 24373479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
